share_log

Clover Biopharmaceuticals' COVID-19 Vaccine Candidate Neutralizes Certain Virus Strains in Phase 3 Trial

Clover Biopharmaceuticals' COVID-19 Vaccine Candidate Neutralizes Certain Virus Strains in Phase 3 Trial

三叶草生物制药公司的新冠肺炎候选疫苗在第三阶段试验中中和某些病毒株
MT Newswires ·  2022/09/05 22:44

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发